Commodore Capital L.P., 10% Owner at Satsuma Pharmaceuticals, Inc. (STSA), sold 3,250,000 shares at $0.71 ($2.3M) on 2022-11-14, disclosed to the SEC on 2022-11-16.
Open-market sale of $2.3M STSA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VERA | BUY | 2023-06-22 | $13.6M | — | Filing → |
| ELVN | BUY | 2023-02-27 | $14K | — | Filing → |
| IMRA | BUY | 2023-02-23 | $284K | — | Filing → |